
---
title: '奥赛康：甲磺酸仑伐替尼胶囊获得药品注册证书'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=7680'
author: 证券时报网
comments: false
date: Fri, 17 Dec 2021 20:30:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=7680'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="http://info.stcn.com/dc/stock/?stockcode=SZ002755" style="color: #2f67d1;text-decoration: none;" code="002755" target="_blank">奥赛康</a>(002755)12月17日晚间公告，子公司江苏<a class="trsHotWords" href="http://info.stcn.com/dc/stock/?stockcode=SZ002755" style="color: #2f67d1;text-decoration: none;" code="002755" target="_blank">奥赛康</a>药业有限公司于近日收到国家药监局核准签发的甲磺酸仑伐替尼胶囊《药品注册证书》。</p>

                  
</div>
            